-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Equal-Weight on Organogenesis Holdings, Raises Price Target to $6

Benzinga·03/05/2025 14:06:32
Listen to the news
Morgan Stanley analyst Drew Ranieri maintains Organogenesis Holdings (NASDAQ:ORGO) with a Equal-Weight and raises the price target from $4 to $6.